Seminars in Nephrology

Does Gender Affirming Hormone Therapy Increase the Risk of Kidney Disease?.  42. 2022

Introduction: The 2022 Acute Kidney Injury: Bench to Bedside Conference.  42. 2022

Where Are They Now: Spatial and Molecular Diversity of Tissue-Resident Macrophages in the Kidney.  42. 2022

The Shared Genetic Basis of Hyperuricemia, Gout, and Kidney Function.  40:586-599. 2020

Ferritins in Kidney Disease.  40:160-172. 2020

Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.  40:138-147. 2020

Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.  38:461-476. 2018

Apolipoprotein L1 Gene Effects on Kidney Transplantation.  37:530-537. 2017

Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.  36:252-261. 2016

Targeting Iron Homeostasis in Acute Kidney Injury.  36:62-70. 2016

Endothelin and Renal Ion and Water Transport.  35:137-144. 2015

Endothelin and the Renal Microcirculation.  35:145-155. 2015

Pathophysiology and Treatment of Resistant Hypertension: The Role of Aldosterone and Amiloride-Sensitive Sodium Channels.  34:532-539. 2014

Fibroblast growth factor 23, vitamin d, and health disparities among african americans with chronic kidney disease.  33:448-456. 2013

Arteriovenous Fistula Failure: Is There a Role for Epigenetic Regulation?.  33:400-406. 2013

Genetic disorders of potassium homeostasis.  33:300-309. 2013

Chronic Kidney Disease in African Americans: Past, Present, and Future: Introduction.  33:407-408. 2013

Balloon-Assisted Maturation (BAM) of the Arteriovenous Fistula: The Good, the Bad, and the Ugly.  32:558-563. 2012

Effect of Dietary Salt on Regulation of TGF-β in the Kidney.  32:269-276. 2012

Heme Oxygenase-1 as a Target for TGF-β in Kidney Disease.  32:277-286. 2012

Population Heterogeneity in the Genetic Control of Serum Urate.  31:420-425. 2011

Uric Acid and Hypertension.  31:441-446. 2011

Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis.  30:164-176. 2010

IgA Glycosylation and IgA Immune Complexes in the Pathogenesis of IgA Nephropathy.  28:78-87. 2008

Hypertension: A companion to brenner and rector's the kidney.  1-872. 2005

Uric acid and hypertension in adolescents.  25:32-38. 2005

Angiotensin II Receptor Type 1 Expression in Erythroid Progenitors: Implications for the Pathogenesis of Postrenal Transplant Erythrocytosis.  24:120-130. 2004

Oxidative Stress in Hypertension and Chronic Kidney Disease: Role of Angiotensin II.  24:101-114. 2004

Issues related to iron replacement in chronic kidney disease.  22:479-487. 2002

Genetic renal tubular disorders of renal ion channels and transporters.  21:81-93. 2001

Prevention, protection, and the intrarenal renin-angiotensin systems.  21:593-602. 2001

Risk and benefit of coronary revascularization in renal transplant candidates.  21:47-51. 2001

Treatment of IgA nephropathy.  20:277-285. 2000

Low renin hypertension in the next millennium.  20:40-46. 2000

Genetic testing for patients with renal disease: Procedures, pitfalls, and ethical considerations.  19:319-326. 1999

Possible mediators in hypertension: Renal factors.  16:134-139. 1996

Monoclonal immunoglobulin light chain-related renal diseases.  13:324-341. 1993

Mechanism of H⁺ secretion in the proximal convoluted tubule.  10:93-103. 1990

Analysis of immunoglobulin heavy chain restriction fragment length polymorphisms in IgA nephropathy..  7:306-310. 1987

IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions..  7:332-335. 1987

Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy..  7:389-392. 1987

Intrarenal feedback control of glomerular filtration rate.  2:289-301. 1982